News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
105 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (18684)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (1160)
Day
1 (214)
2 (187)
3 (160)
4 (138)
5 (74)
7 (52)
8 (139)
9 (151)
10 (114)
11 (132)
12 (58)
14 (27)
15 (145)
16 (92)
17 (98)
18 (106)
19 (70)
21 (14)
22 (92)
23 (109)
24 (105)
25 (106)
26 (50)
28 (28)
29 (103)
30 (161)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
Day
1
2
3
4
5
7
8
9
10
11
12
14
15
16
17
18
19
21
22
23
24
25
26
28
29
30
Business
Big Pharma restructures to ride out ‘existential risk’
Even biopharma’s biggest players have been forced to take a hard look at their businesses and realign their cost structures to cope with the continued and compounding challenges plaguing the industry.
June 24, 2026
·
10 min read
·
Tristan Manalac
Career Advice
The most dangerous person in the company
Controlling CEOs, manipulative middle managers and high-performing jerks can damage employees’ trust in employers and motivate them to hit the job market. Kaye/Bassman’s Michael Pietrack discusses the problematic behaviors executives must watch for in the workplace.
June 24, 2026
·
5 min read
·
Michael Pietrack
Opinion
FDA uncertainty adds risk to biopharma deals
While merger and acquisition activity has been robust of late, frequent changes in guidance and leadership at the regulator add risk to any transaction.
June 24, 2026
·
3 min read
·
Jessica Bisignano
Press Releases
Rapalogix Health Closes $20 Million Series A Financing to Accelerate Re-Q Health Expansion and Advance Prescription Therapeutics Pipeline
June 24, 2026
·
2 min read
Press Releases
DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction
June 24, 2026
·
9 min read
Press Releases
Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board
June 24, 2026
·
5 min read
Press Releases
VectorBuilder Partners With MaxCyte® to Advance Clinical-Grade Cell Engineering
June 24, 2026
·
5 min read
Press Releases
Susan G. Komen® Awards $15.4 Million In Research Grants to Accelerate Breakthroughs in Breast Cancer Care
June 24, 2026
·
6 min read
Press Releases
Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma
June 24, 2026
·
4 min read
Press Releases
ŌURA and LillyDirect to Expand Support for People Using GLP-1 Therapies with New Tools and Savings Options
June 24, 2026
·
3 min read
1 of 11
Next